Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
01 1Rampex Labs
02 1Suanfarma
03 1Tagoor Laboratories
04 1AR Life Sciences
05 1Anhui HaiKang Pharmaceutical Co. Ltd
06 1Dasami Lab
07 1Everest Organics
08 1Kekule Pharma
09 1Kores India Limited
10 1Luna Chemicals
11 1Ocimum Labs
12 1Riddhesh Pharmachem
13 1Shouyuan Chemical
14 1Sms Lifesciences
15 1Srini Pharmaceuticals
16 1Synthland Limited
17 1Zhejiang Jiuzhou Pharmaceutical
Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
N-(2-Methyl-5-Aminophenyl)-4-(3-Pyridyl)-2- Pyrimi...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in a...
Suanfarma, at the Core of a Better Life.
2-(5-Amino-2-Methylanilino)-4-(3-Pyridyl) Pyrimidi...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Suanfarma is a B2B life sciences company focused on developing, manufacturing, and distributing high-quality ingredients for the pharmaceutical industry in an innovative and sustainable...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-growth therapeutic areas. ...
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, ad...
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients who are looking for manuf...
N-(2-METHYL-5-AMINOPHENYL)-4- (PYRIDINE-3-YL) PYRI...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non Govt Company. This compan...
N-(5-Amino-2-Methylphenyl)-4-(3-Pyridyl)-2-Pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : The Company was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole,Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, etc., ha...
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : Founded in 1986, Kekule has developed from a manufacturer of few molecules to a preferred vendor for many complex molecules requiring multistage synthesis. Working with customers across...
N-(5-amino-2-methylphenyl)-4-(3-pyridinyl)-2-pyrid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : The division was established in 1981 as a Specialty Chemicals Division with a focus to manufacture specialty chemicals and pharmaceutical intermediates. In April 2006, the division has ...
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid...
CAS Number : 152460-10-1
End Use API :
End Use API : Imatinib Mesylate
About the Company : LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate chemicals for generic pharmaceutical companies. Our Development T...
